Suppr超能文献

慢性盆腔疼痛综合征(CPPS)中针对精浆的自身免疫性T细胞反应。

Autoimmune T cell responses to seminal plasma in chronic pelvic pain syndrome (CPPS).

作者信息

Batstone G R D, Doble A, Gaston J S H

机构信息

Department of Urology, Addenbrooke's Hospital, Cambridge, UK.

出版信息

Clin Exp Immunol. 2002 May;128(2):302-7. doi: 10.1046/j.1365-2249.2002.01853.x.

Abstract

The aetiology of chronic prostatitis is not understood. The aim of this study is to investigate an autoimmune hypothesis by looking for T cell proliferation in response to proteins of the seminal plasma. We studied peripheral blood mononuclear cell proliferation from 20 patients with chronic prostatitis and 20 aged-matched controls in response to serial dilutions of seminal plasma (SP) from themselves (autologous SP) and from a healthy individual without the disease (allo-SP). We found that the patients have a statistically greater lymphocyte proliferation to autologous SP at the 1/50 dilution on day 6 compared to controls (P = 0 x 01). They also have a greater proliferation to allo-SP on both day 5 (P = 0 x 001) and day 6 (P = 0 x 01) at the same dilution. Using a stimulation index (SI) of 9 to either autologous SP or allo-SP on day 6 at the 1/50 dilution as a definition of a proliferative response to SP, then 13/20 patients as compared to 3/20 controls showed a proliferative response to SP (P = 0 x 003, Fishers exact test). These data support an autoimmune hypothesis for chronic prostatitis.

摘要

慢性前列腺炎的病因尚不明确。本研究旨在通过观察T细胞对精浆蛋白的增殖反应来探究自身免疫假说。我们研究了20例慢性前列腺炎患者和20例年龄匹配的对照者的外周血单核细胞对自身精浆(自体精浆)和来自一名无该疾病的健康个体的精浆(同种异体精浆)系列稀释液的增殖反应。我们发现,与对照组相比,患者在第6天对1/50稀释度的自体精浆的淋巴细胞增殖在统计学上显著更高(P = 0.01)。在相同稀释度下,他们在第5天(P = 0.001)和第6天(P = 0.01)对同种异体精浆的增殖也更高。以第6天1/50稀释度下对自体精浆或同种异体精浆的刺激指数(SI)为9作为对精浆增殖反应的定义,那么与20例对照者中的3例相比,20例患者中有13例显示出对精浆的增殖反应(P = 0.003,Fisher精确检验)。这些数据支持慢性前列腺炎的自身免疫假说。

相似文献

1
Autoimmune T cell responses to seminal plasma in chronic pelvic pain syndrome (CPPS).
Clin Exp Immunol. 2002 May;128(2):302-7. doi: 10.1046/j.1365-2249.2002.01853.x.
2
Autoimmune prostatitis: evidence of T cell reactivity with normal prostatic proteins.
Urology. 1997 Dec;50(6):893-9. doi: 10.1016/S0090-4295(97)00456-1.
4
PSA is a candidate self-antigen in autoimmune chronic prostatitis/chronic pelvic pain syndrome.
Prostate. 2000 Jun 15;44(1):49-54. doi: 10.1002/1097-0045(20000615)44:1<49::aid-pros7>3.0.co;2-7.
7
Seminal plasma cytokine levels in the diagnosis of chronic pelvic pain syndrome.
Int J Urol. 2001 Sep;8(9):495-9. doi: 10.1046/j.1442-2042.2001.00358.x.
8
Chronic prostatitis/chronic pelvic pain pyndrome): seminal markers of inflammation.
World J Urol. 2003 Jun;21(2):82-5. doi: 10.1007/s00345-003-0330-7. Epub 2003 Apr 11.
9
Nerve growth factor and chronic prostatitis/chronic pelvic pain syndrome.
Urology. 2002 Apr;59(4):603-8. doi: 10.1016/s0090-4295(01)01597-7.

引用本文的文献

1
IGF1R Promotes Th17/Treg Cell Development in Experimental Autoimmune Prostatitis.
J Inflamm Res. 2025 Apr 30;18:5759-5775. doi: 10.2147/JIR.S508576. eCollection 2025.
2
CD8 T cells are dispensable for experimental autoimmune prostatitis induction and chronic pelvic pain development.
Front Immunol. 2024 May 14;15:1387142. doi: 10.3389/fimmu.2024.1387142. eCollection 2024.
3
The Protective Effects of Bushen Daozhuo Granule on Chronic Non-bacterial Prostatitis.
Front Pharmacol. 2024 Jan 4;14:1281002. doi: 10.3389/fphar.2023.1281002. eCollection 2023.
6
Morphological study of chronic prostatitis-chronic pelvic pain syndrome (CP/CPPS) normal modeling dose of T2 peptide in mice.
Int Urol Nephrol. 2022 Jun;54(6):1199-1206. doi: 10.1007/s11255-022-03185-6. Epub 2022 Apr 19.
7
Diagnostic and Management Strategies for Patients with Chronic Prostatitis and Chronic Pelvic Pain Syndrome.
Drugs Aging. 2021 Oct;38(10):845-886. doi: 10.1007/s40266-021-00890-2. Epub 2021 Sep 29.
8
T2 Peptide Represents a Major Autoantigen Epitope in Experimental Autoimmune Prostatitis.
Inflammation. 2021 Feb;44(1):243-248. doi: 10.1007/s10753-020-01326-6. Epub 2020 Aug 22.
9
Immunological Mechanisms Underlying Chronic Pelvic Pain and Prostate Inflammation in Chronic Pelvic Pain Syndrome.
Front Immunol. 2017 Jul 31;8:898. doi: 10.3389/fimmu.2017.00898. eCollection 2017.
10
New therapy with ASC-J9® to suppress the prostatitis via altering the cytokine CCL2 signals.
Oncotarget. 2016 Oct 11;7(41):66769-66775. doi: 10.18632/oncotarget.11484.

本文引用的文献

3
PSA is a candidate self-antigen in autoimmune chronic prostatitis/chronic pelvic pain syndrome.
Prostate. 2000 Jun 15;44(1):49-54. doi: 10.1002/1097-0045(20000615)44:1<49::aid-pros7>3.0.co;2-7.
10
Evaluation of seminal plasma parameters in patients with chronic prostatitis or leukocytospermia.
Andrologia. 1998;30 Suppl 1:41-7. doi: 10.1111/j.1439-0272.1998.tb02825.x.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验